CUE BIOPHARMA INC's ticker is CUE and the CUSIP is 22978P106. A total of 79 filers reported holding CUE BIOPHARMA INC in Q2 2023. The put-call ratio across all filers is 0.49 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $446,250 | +25.3% | 125,000 | 0.0% | 0.06% | -17.4% |
Q4 2022 | $356,250 | -20.1% | 125,000 | -37.5% | 0.07% | -45.7% |
Q3 2022 | $446,000 | +79.1% | 200,000 | +100.0% | 0.13% | +56.8% |
Q2 2022 | $249,000 | -82.9% | 100,000 | -20.0% | 0.08% | -86.6% |
Q2 2021 | $1,456,000 | +19.3% | 125,000 | +25.0% | 0.61% | +19.1% |
Q1 2021 | $1,220,000 | -55.8% | 100,000 | -54.7% | 0.51% | -63.5% |
Q4 2020 | $2,761,000 | -19.0% | 220,714 | -2.6% | 1.39% | -28.4% |
Q3 2020 | $3,410,000 | +225.1% | 226,573 | +429.4% | 1.94% | +177.5% |
Q2 2020 | $1,049,000 | +40.1% | 42,800 | -51.7% | 0.70% | -30.0% |
Q1 2020 | $749,000 | -49.0% | 88,670 | -4.1% | 1.00% | +352.9% |
Q4 2019 | $1,469,000 | – | 92,500 | – | 0.22% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Slate Path Capital LP | 890,000 | $7,503,000 | 0.50% |
Nantahala Capital Management | 1,378,198 | $11,618,000 | 0.43% |
683 Capital Management, LLC | 300,000 | $2,529,000 | 0.28% |
Rock Creek Group, LP | 42,505 | $358,000 | 0.17% |
SPHERA FUNDS MANAGEMENT LTD. | 50,000 | $422,000 | 0.06% |
Parian Global Management LP | 11,000 | $93,000 | 0.04% |
Sigma Planning Corp | 60,210 | $508,000 | 0.02% |
D'Orazio & Associates, Inc. | 2,000 | $17,000 | 0.01% |
OXFORD ASSET MANAGEMENT LLP | 26,602 | $224,000 | 0.01% |
STIFEL FINANCIAL CORP | 55,855 | $471,000 | 0.00% |